Age-related macular degeneration: Genome-wide association studies to translation

Genetics in Medicine

Volumn 18, Issue 4, 2016, Pages 283-289

  Black, James R M ^a   Clark, Simon J ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

age related macular degeneration; complement cascade; genome wide association studies; novel therapeutics

Indexed keywords

AGE RELATED MACULAR DEGENERATION; CHROMOSOME 1; CHROMOSOME 10; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HERITABILITY; HUMAN; MOLECULAR PATHOLOGY; PATHOGENESIS; PREDICTIVE VALUE; REVIEW; GENETIC PREDISPOSITION; GENOME-WIDE ASSOCIATION STUDY; INHERITANCE; MACULAR DEGENERATION; MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHERITANCE PATTERNS; MACULAR DEGENERATION; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84962374584     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.70     Document Type: Review

References (65)

1. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-1320.
2. Smith GD. Mendelian randomization for strengthening causal inference in observational studies: application to gene x environment interactions. Perspect Psychol Sci 2010;5:527-545.
3. Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009;19:212-219.
4. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-1517.
5. Lander ES. The new genomics: global views of biology. Science 1996;274:536-539.
6. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-Alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-654.
7. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-389.
8. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463.
9. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007;39:596-604.
10. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885.
11. Maier LM, Hafler DA. The developing mosaic of autoimmune disease risk. Nat Genet 2008;40:131-132.
12. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011;88:76-82.
13. Wood AR, Esko T, Yang J, et al.; Electronic Medical Records and Genomics (eMEMERGEGE) Consortium; MIGen Consortium; PAGEGE Consortium; LifeLines Cohort Study. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 2014;46:1173-1186.
14. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet 2012;379:1728-1738.
15. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000;14:835-846.
16. Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol 2012;96:752-756.
17. Sobrin L, Seddon JM. Nature and nurture-genes and environment-predict onset and progression of macular degeneration. Prog Retin Eye Res 2014;40:1-15.
18. Abecasis GR, Yashar BM, Zhao Y, et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 2004;74:482-494.
19. Fisher SA, Abecasis GR, Yashar BM, et al. Meta-Analysis of genome scans of age-related macular degeneration. Hum Mol Genet 2005;14:2257-2264.
20. Pickering MC, Cook HT, Warren J, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002;31:424-428.
21. Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol 1989;73:900-906.
22. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20:705-732.
23. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-424.
24. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005;102: 7227-7232.
25. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-421.
26. Day AJ, Willis AC, Ripoche J, Sim RB. Sequence polymorphism of human complement factor H. Immunogenetics 1988;27:211-214.
27. Sofat R, Casas JP, Webster AR, et al. Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol 2012;41:250-262.
28. Fritsche LG, Chen W, Schu M, et al.; AMD Gene Consortium. Seven new loci associated with age-related macular degeneration. Nat Genet 2013;45: 433-9, 439e1.
29. Clark SJ, Higman VA, Mulloy B, et al. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-Associated form. J Biol Chem 2006;281:24713-24720.
30. Ormsby RJ, Ranganathan S, Tong JC, et al. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:1763-1770.
31. Clark SJ, Perveen R, Hakobyan S, et al. Impaired binding of the age-related macular degeneration-Associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem 2010;285:30192-30202.
32. Mullins RF, Schoo DP, Sohn EH, et al. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. Am J Pathol 2014;184:3142-3153.
33. Clark SJ, Bishop PN, Day AJ. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochem Soc Trans 2010;38:1342-1348.
34. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005;77:389-407.
35. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227-3236.
36. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314: 992-993.
37. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet agerelated macular degeneration. Science 2006;314:989-992.
38. Cameron DJ, Yang Z, Gibbs D, et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 2014;6:1122-1125.
39. Gold B, Merriam JE, Zernant J, et al.; AMD Genetics Clinical Study Group. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006;38:458-462.
40. Yates JR, Sepp T, Matharu BK, et al.; Genetic Factors in AMD Study Group. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007;357:553-561.
41. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 2009;17:100-104.
42. Chen W, Stambolian D, Edwards AO, et al.; Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Genetic variants near TIMP3 and high-density lipoprotein-Associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010;107: 7401-7406.
43. Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 2011;20:3699-3709.
44. Arakawa S, Takahashi A, Ashikawa K, et al. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet 2011;43:1001-1004.
45. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012;90:7-24.
46. Hirschhorn JN, Gajdos ZK. Genome-wide association studies: results from the first few years and potential implications for clinical medicine. Annu Rev Med 2011;62:11-24.
47. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 2007;17: 1520-1528.
48. Porter LF, Black GC. Personalized ophthalmology. Clin Genet 2014;86:1-11.
49. Hageman GS, Gehrs K, Lejnine S, et al. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genomics 2011;5:420-440.
50. Perlee LT, Bansal AT, Gehrs K, et al. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmology 2013;120:1880-1892.
51. Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med 2014;370:985-988.
52. Mitchell P. Smoking and the 5-year incidence of age-related maculopathy. Arch Ophthalmol 2002;120:1357.
53. Hollands GJ, Whitwell SC, Parker RA, et al. Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial. BMJ 2012;345:e4708.
54. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2012;11:CD000254.
55. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-Analysis. BMJ 2007;335:755.
56. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351: 2805-2816.
57. Rosenfeld PJ, Brown DM, Heier JS, et al.; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355: 1419-1431.
58. Martin DF, Maguire MG, Ying G, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-1908.
59. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology 2014;121:693-701.
60. Schramm EC, Clark SJ, Triebwasser MP, Raychaudhuri S, Seddon JM, Atkinson JP. Genetic variants in the complement system predisposing to age-related macular degeneration: a review. Mol Immunol 2014;61:118-125.
61. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-753.
62. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001;69:124-137.
63. Raychaudhuri S, Iartchouk O, Chin K, et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 2011;43:1232-1236.
64. Moutray T, Chakravarthy U. Age-related macular degeneration: current treatment and future options. Ther Adv Chronic Dis 2011;2:325-331.
65. Clark SJ, Ridge LA, Herbert AP, et al. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol 2013;190:2049-2057.